← Back to Search

Behavioural Intervention

Resistance Exercise for Osteoporosis

N/A
Waitlist Available
Led By HARSHVARDHAN SINGH, PT, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with low bone mass
Independent ambulatory
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will test a new muscle-strengthening exercise to see if it is feasible for postmenopausal women with low bone mass.

Who is the study for?
This trial is for postmenopausal women who can walk on their own and have been diagnosed with low bone mass. It's not suitable for those with secondary osteoporosis, uncontrolled high blood pressure, current non-zoledronic acid osteoporosis treatments, liver or kidney disease, unmanaged thyroid issues, recent cancer history, previous year resistance training, inability to walk independently or a fragility fracture.Check my eligibility
What is being tested?
The study tests a new muscle-strengthening exercise program over six months to see if it's doable for women with weak bones after menopause. Participants are randomly chosen to either join the exercise group or be in a control group without this specific training.See study design
What are the potential side effects?
Since the intervention involves physical exercise training, potential side effects may include muscle soreness, joint pain or discomfort during and after workouts. However, these are common reactions to starting any new workout regimen.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with low bone density.
Select...
I can walk by myself without help.
Select...
I can walk by myself without help.
Select...
I can walk on my own without help.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Bone and Bones
Secondary outcome measures
Muscle strength
Oxygen uptake (VO2)
Physical activity: International Physical Activity Questionnaire (IPAQ)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise trainingExperimental Treatment1 Intervention
The exercise training group will receive progressive muscle resistive exercise, 10 sets of exercises for 2 times per week for a total of 6 months.
Group II: ControlActive Control1 Intervention
The control group will be asked to maintain their normal lifestyle and will be advised to continue their standard care of treatment.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,565 Previous Clinical Trials
2,268,314 Total Patients Enrolled
16 Trials studying Osteoporosis
581,010 Patients Enrolled for Osteoporosis
HARSHVARDHAN SINGH, PT, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

Novel Resistance Exercise (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05060380 — N/A
Osteoporosis Research Study Groups: Exercise training, Control
Osteoporosis Clinical Trial 2023: Novel Resistance Exercise Highlights & Side Effects. Trial Name: NCT05060380 — N/A
Novel Resistance Exercise (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05060380 — N/A
Osteoporosis Patient Testimony for trial: Trial Name: NCT05060380 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research require participants to be within a certain age range?

"This trial is open to applicants aged 55-85, with 19 clinical trials targeting those below 18 years old and 236 for elderly patients."

Answered by AI

What demographic is most likely to benefit from this trial?

"This osteoporosis trial is open to 44 individuals aged between 55 and 85. Key requirements for eligibility include being able to ambulate independently."

Answered by AI

Are volunteers still being sought for this experiment?

"Per the information on clinicaltrials.gov, this medical study is not currently accepting participants. The trial was first posted on May 1st 2023 and last updated a few months ago in November 16th 2022. Although inactive at present, there are 260 other trials that have openings for volunteers now."

Answered by AI

Who else is applying?

What state do they live in?
Ohio
Georgia
How old are they?
18 - 65
What site did they apply to?
University of Alabama at Birmingham
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I haven’t tried any drugs just go to the gym to exercise a couple of days a week and sometimes swim in the swimming pool.
PatientReceived 2+ prior treatments
~29 spots leftby Jun 2025